| Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children MR Capeding, S Teshome, T Saluja, KA Syed, DR Kim, JY Park, JS Yang, ... Vaccine 36 (26), 3794-3801, 2018 | 40 | 2018 |
| Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome, E Alberto, ... EClinicalMedicine 27, 2020 | 19 | 2020 |
| Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report MR Capeding, E Alberto, A Sil, T Saluja, S Teshome, DR Kim, JY Park, ... Vaccine 38 (28), 4476-4483, 2020 | 15 | 2020 |
| A phase 3, multicenter, randomized, controlled trial to evaluate immune equivalence and safety of multidose and single-dose formulations of vi-DT typhoid conjugate vaccine in … JC Carlos, BT Tadesse, C Borja-Tabora, E Alberto, MC Ylade, A Sil, ... The Lancet Regional Health–Western Pacific 24, 2022 | 3 | 2022 |
